Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions

NCT02577315 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Empagliflozin
DRUG: Metformin
DRUG: Empagliflozin
DRUG: Metformin

Sponsor

Boehringer Ingelheim